Poon, Shi HuiSim, KangBaldessarini, Ross2016-04-012015Poon, Shi Hui, Kang Sim, and Ross J. Baldessarini. 2015. “Pharmacological Approaches for Treatment-resistant Bipolar Disorder.” Current Neuropharmacology 13 (5): 592-604. doi:10.2174/1570159X13666150630171954. http://dx.doi.org/10.2174/1570159X13666150630171954.1570-159Xhttp://nrs.harvard.edu/urn-3:HUL.InstRepos:26318671Bipolar disorder is prevalent, with high risks of disability, substance abuse and premature mortality. Treatment responses typically are incomplete, especially for depressive components, so that many cases can be considered “treatment resistant.” We reviewed reports on experimental treatments for such patients: there is a striking paucity of such research, mainly involving small incompletely controlled trials of add-on treatment, and findings remain preliminary. Encouraging results have been reported by adding aripiprazole, bupropion, clozapine, ketamine, memantine, pramipexole, pregabalin, and perhaps tri-iodothyronine in resistant manic or depressive phases. The urgency of incomplete responses in such a severe illness underscores the need for more systematic, simpler, and better controlled studies in more homogeneous samples of patients.en-USBipolar disorderdepressionexperimental treatmentsmaniatreatment-resistance.Journal Article2016-04-0110.2174/1570159X13666150630171954